Mark Joing is the Founder & CEO at Mojo Trials, a startup life sciences service provider delivering virtual site monitoring in clinical trials. He is also the Chief Operating and Financial Officer at Sanaby Health, a Special Purpose Acquisition Company created to accelerate innovation in healthcare. His 25+ year career in biopharma includes executive roles...
73% of sites reported using paper as the primary means of data collection In a 2018 CRIO site survey with over 100 respondents, sites reported that they use their Electronic Medical Record (EMR) primarily for patient recruitment purposes, but not for source data collection. 62% of site respondents reported that they use the EMR as...
Reflections on the Summit The 2021 Global Site Solutions Summit, hosted by the Society for Clinical Research Sites, was an amazing event. The first in-person event that our company has attended in 18 months, the Summit provided an opportunity for CRIO to meet new people and reconnect with clients and friends alike. Post-Pandemic Trends, Here...
What’s wrong with the way that most sites have been recording data for decades? While much of research data is still being collected on paper, digital adoption across source, regulatory and remote monitoring is rapidly increasing among sponsors, CROs, and research sites. Many of the challenges that Principal Investigators (PIs) face during the conduct of...
Clinical Research IO (CRIO)’s recent site survey showed that most sites have recovered business lost during the pandemic, are adjusting to the decentralized clinical trial model, and have implemented their own software in response. At the beginning of the pandemic, CRIO conducted a survey to look at the impact of coronavirus on research sites. By...
CRIO has been highlighted among the top solutions that help researchers track application deadlines, project milestones, and participant demographics. BOSTON, MA – August 24, 2021 – Clinical Research IO (CRIO), a Boston-based company working to transform the clinical research industry with the latest in the cloud and SaaS technology, has been named among the best...
Leadership’s role in empowering emotional resilience and adaptation in the clinical research industry. For the last 25 years, the founders of BioNTech have been dedicated to using mRNA technology in the treatment of cancer. In January 2020, the company’s leadership identified that their innovative technology could be applied to a COVID-19 vaccine – and the...
Remote consent is one of the main technological and operational advantages that support direct-to-patient recruitment. In Part 3 of our 7-part webinar, join the conversation around the willingness to adopt remote consenting services, as well as the challenges of multinational clinical trials covering different languages. Topics covered over the course of 7 sessions include: Part...
In the latest virtual conference hosted by ACRP, Innovation in the Era of COVID, Raymond Nomizu of Clinical Research IO and Jessica Branning of ClinCloud Clinical Research discussed electronic Source (eSource) and how it has shaped the future of clinical research. Ms. Branning’s site, ClinCloud, was built ground-up on a technological platform centered around CRIO....
Striving for site success and business continuity amidst our global pandemic? Virtual monitoring bypasses the need for travel, made nearly impossible with the coronavirus, and becomes a critical technological solution for the kind of business continuity that keeps the industry reliable and strong. You can turn complexity into meaningful change. In this webinar, Raymond Nomizu,...
Most clinical trials are conducted with onsite monitoring, where a clinical research assistant (CRA) visits the site to perform source data verification, drug accountability, and other review functions. As COVID has imposed significant travel restrictions and stay at home mandates, many CRAs cannot currently perform on-site visits; even if they could, many of their sites...
To continue operating throughout the pandemic, research sites quickly implemented a variety of measures and procedures (i.e., PPE requirements, increased sanitation, COVID screening, IP handling systems, patient transportation systems, limitations on number of people on site, etc.). While these measures continue to be necessary, they have increased site workload and consequently led to an unprecedented level of financial strain....
